Document Detail

Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.
MedLine Citation:
PMID:  17186796     Owner:  NLM     Status:  MEDLINE    
Long-term in vitro compatibility of desoximetasone and tacrolimus ointments prompted the current trial in humans. We aimed to evaluate the efficacy of twice-daily simultaneous application of desoximetasone and tacrolimus in the treatment of atopic dermatitis versus tacrolimus monotherapy. Eighty-two subjects were treated in this multicenter, single-group, double-blinded, paired, 3-week follow-up clinical study of desoximetasone 0.25% and tacrolimus 0. 1% ointments versus tacrolimus 0.1% ointment and vehicle. Subjects were treated twice daily for 21 days or until clearing. Safety and efficacy were assessed at days 3, 7, 14, and 21. The combination of desoximetasone and tacrolimus ointment was superior to tacrolimus alone (P=.0002) in treating atopic dermatitis as measured by the summary of the scores for erythema, lichenification, pruritus, scaling/dryness, and oozing/crusting. Of note, pruritus at the application site was diminished in subjects treated with desoximetasone and tacrolimus together compared with tacrolimus alone (P=.04). Combination treatment with desoximetasone and tacrolimus offered increased efficacy and tolerability over tacrolimus alone in patients with atopic dermatitis.
Adelaide A Hebert; John Koo; Joseph Fowler; Brian Berman; Carl Rosenberg; Jacob Levitt
Related Documents :
3378486 - Nasal eosinophilia in children: its use in the nasal allergen provocation test.
11906366 - The association of airway hyperresponsiveness and tuberculin responses.
21062476 - Validation of epidemiological tools for eczema diagnosis in brazilian children: the isa...
19851046 - Cardiac autonomic imbalance in children with allergic rhinitis.
25243496 - Doppler ultrasonographic evaluation of the carotid and vertebral arteries in children w...
10838676 - Ptsd scale of the child behavior checklist: concurrent and discriminant validity with n...
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cutis     Volume:  78     ISSN:  0011-4162     ISO Abbreviation:  Cutis     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-12-25     Completed Date:  2007-03-16     Revised Date:  2013-09-12    
Medline Journal Info:
Nlm Unique ID:  0006440     Medline TA:  Cutis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  357-63     Citation Subset:  IM    
University of Texas Medical School, Houston, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Anti-Inflammatory Agents / administration & dosage*,  adverse effects
Dermatitis, Atopic / drug therapy*
Desoximetasone / administration & dosage*,  adverse effects
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Follow-Up Studies
Immunosuppressive Agents / administration & dosage*,  adverse effects
Middle Aged
Tacrolimus / administration & dosage*,  adverse effects
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Immunosuppressive Agents; 0/Ointments; 109581-93-3/Tacrolimus; 382-67-2/Desoximetasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type...
Next Document:  Self-adaptation in next-generation Internet networks: how to react to traffic changes while respecti...